A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
2018 · Nature Communications · 185 citations
https://doi.org/10.1038/s41467-018-05032-8
J
Jungmin Choi
Korea University(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
321
Papers
7.0K
Citations
36
h-index
76
i10-index
Jungmin Choi is an academic researcher from Korea University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & RNA modifications and cancer & Cytokine Signaling Pathways and Interactions. The author has an h-index of 36, co-authored 273 publications.
ORCID: 0000-0002-8614-0973Papers by this author
worksTargeted mutagenesis in mouse cells and embryos using an enhanced prime editor
2021 · Genome biology · 127 citations
https://doi.org/10.1186/s13059-021-02389-w
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019 · Proceedings of the National Academy of Sciences · 93 citations
https://doi.org/10.1073/pnas.1911385116
Collagen IV Gene Mutations in Adults With Bilateral Renal Cysts and CKD
2019 · Kidney International Reports · 58 citations
https://doi.org/10.1016/j.ekir.2019.09.004
Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer
2023 · Journal of Thoracic Oncology · 56 citations
https://doi.org/10.1016/j.jtho.2023.10.001
Exome Sequencing Implicates Impaired GABA Signaling and Neuronal Ion Transport in Trigeminal Neuralgia
2020 · iScience · 46 citations
https://doi.org/10.1016/j.isci.2020.101552
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat